プレフィルドシリンジの世界市場：洞察、競合情勢、市場予測：2030年

世界のプレフィルドシリンジの市場規模は、2023年に114億8,000万米ドルとなりました。同市場は、2024年から2030年までの予測期間中に10.44％のCAGRで拡大し、2030年には208億3,000万米ドルに達すると予測されていす。プレフィルドシリンジの需要は、それぞれ糖尿病や関節リウマチなどの慢性疾患や自己免疫疾患の有病率の増加、生物学的製剤の人気の高まり、薬剤の自己投与の人気の高まり、従来のシリンジやバイアルに代わる便利な選択肢を提供するため、成長が促進されています。

プレフィルドシリンジ市場は、糖尿病などの様々な慢性疾患の有病率の上昇により、市場収益の増加が見込まれています。

プレフィルドシリンジは使いやすく、持ち運びが可能で、見た目も目立たないものとなっています。プレフィルドシリンジの成長を支えるもう一つの重要な要因は、生物学的製剤の人気の高まりです。低分子薬は一般に経口摂取が可能だが、複雑なタンパク質やペプチドを錠剤にした生物製剤はほとんど効果がないです。このため、プレフィルドシリンジのような侵襲性の低い形態のドラッグデリバリーが生物学的製剤の包装用容器として選択されるようになり、プレフィルドシリンジ市場の製品需要を押し上げています。

当レポートでは、世界のプレフィルドシリンジ市場について調査し、市場の概要とともに、製品デザイン別、素材別、使用法別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 プレフィルドシリンジ市場レポートのイントロダクション

第2章 プレフィルドシリンジ市場のエグゼクティブサマリー

第3章 規制と特許の分析

• 米国
• 欧州
• 日本

第4章 プレフィルドシリンジ市場の主な要因分析

• プレフィルドシリンジ市場の促進要因
• プレフィルドシリンジ市場の抑制要因と課題
• プレフィルドシリンジ市場の機会

第5章 プレフィルドシリンジ市場におけるポーターのファイブフォース分析

第6章 プレフィルドシリンジ市場に対するCOVID-19の影響分析

第7章 プレフィルドシリンジの市場概要

• 製品デザイン別
• 素材別
• 使用法別
• エンドユーザー別
• 地域別

第8章 プレフィルドシリンジ市場の世界企業シェア分析-主要3～5社

第9章 プレフィルドシリンジ市場の企業と製品プロファイル

• BD
• NIPRO Pharma
• Taisei Kako Co.,Ltd
• TERUMO PHARMACEUTICAL SOLUTIONS
• SCHOTT AG
• Gerresheimer AG
• West Pharmaceutical Services, Inc.
• Dali Medical Devices
• Stevanato Group
• Credence MedSystems, Inc.
• Baxter
• MAEDA INDUSTRY Co., Ltd.
• MedXL Inc
• IRISYS, LLC
• Sandoz International GmbH
• Pfizer Inc
• Vetter
• Weigao Group
• Fresenius Kabi
• Catalent, Inc

第10章 プロジェクトのアプローチ

第11章 KOLの見解

第12章 DelveInsightのサービス内容

第13章 免責事項

第14章 DelveInsightについて

List of Tables

• Table 1: Competitive Analysis
• Table 2: COVID-19 Impact Analysis
• Table 3: Prefilled Syringes in Global (2021-2030)
• Table 4: Prefilled Syringes in Global by Product Design (2021-2030)
• Table 5: Prefilled Syringes in Global by Material (2021-2030)
• Table 6: Prefilled Syringes in Global by Usability (2021-2030)
• Table 7: Prefilled Syringes in Global by End User (2021-2030)
• Table 8: Prefilled Syringes in Global by Geography (2021-2030)
• Table 9: Prefilled Syringes in North America (2021-2030)
• Table 10: Prefilled Syringes in North America by Product Design (2021-2030)
• Table 11: Prefilled Syringes in North America by Material (2021-2030)
• Table 12: Prefilled Syringes in North America by Usability (2021-2030)
• Table 13: Prefilled Syringes in North America by End User (2021-2030)
• Table 14: Prefilled Syringes in North America by Country (2021-2030)
• Table 15: Prefilled Syringes in the US (2021-2030)
• Table 16: Prefilled Syringes in Canada (2021-2030)
• Table 17: Prefilled Syringes in Mexico (2021-2030)
• Table 18: Prefilled Syringes in Europe (2021-2030)
• Table 19: Prefilled Syringes in Europe by Product Design (2021-2030)
• Table 20: Prefilled Syringes in Europe by Material (2021-2030)
• Table 21: Prefilled Syringes in Europe by Usability (2021-2030)
• Table 22: Prefilled Syringes in Europe by End User (2021-2030)
• Table 23: Prefilled Syringes in Europe by Country (2021-2030)
• Table 24: Prefilled Syringes in France (2021-2030)
• Table 25: Prefilled Syringes in Germany (2021-2030)
• Table 26: Prefilled Syringes in the United Kingdom (2021-2030)
• Table 27: Prefilled Syringes in Italy (2021-2030)
• Table 28: Prefilled Syringes in Spain (2021-2030)
• Table 29: Prefilled Syringes in Russia (2021-2030)
• Table 30: Prefilled Syringes in Rest of Europe (2021-2030)
• Table 31: Prefilled Syringes in APAC (2021-2030)
• Table 32: Prefilled Syringes in APAC by Product Design (2021-2030)
• Table 33: Prefilled Syringes in APAC by Material (2021-2030)
• Table 34: Prefilled Syringes in APAC by Usability (2021-2030)
• Table 35: Prefilled Syringes in APAC by End User (2021-2030)
• Table 36: Prefilled Syringes in APAC by Country (2021-2030)
• Table 37: Prefilled Syringes in China (2021-2030)
• Table 38: Prefilled Syringes in Japan (2021-2030)
• Table 39: Prefilled Syringes in India (2021-2030)
• Table 40: Prefilled Syringes in Australia (2021-2030)
• Table 41: Prefilled Syringes in South Korea (2021-2030)
• Table 42: Prefilled Syringes in Rest of APAC (2021-2030)
• Table 43: Prefilled Syringes in Rest of World (2021-2030)
• Table 44: Prefilled Syringes in RoW by Product Design (2021-2030)
• Table 45: Prefilled Syringes in RoW by Material (2021-2030)
• Table 46: Prefilled Syringes in RoW by Usability (2021-2030)
• Table 47: Prefilled Syringes in RoW by End User (2021-2030)
• Table 48: Prefilled Syringes in RoW by Region (2021-2030)
• Table 49: Prefilled Syringes in Middle East (2021-2030)
• Table 50: Prefilled Syringes in Africa (2021-2030)
• Table 51: Prefilled Syringes in South America (2021-2030)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: COVID-19 Impact Analysis
• Figure 3: Prefilled Syringes in Global (2021-2030)
• Figure 4: Prefilled Syringes in Global by Product Design (2021-2030)
• Figure 5: Prefilled Syringes in Global by Material (2021-2030)
• Figure 6: Prefilled Syringes in Global by Usability (2021-2030)
• Figure 7: Prefilled Syringes in Global by End User (2021-2030)
• Figure 8: Prefilled Syringes in Global by Geography (2021-2030)
• Figure 9: Prefilled Syringes in North America (2021-2030)
• Figure 10: Prefilled Syringes in North America by Product Design (2021-2030)
• Figure 11: Prefilled Syringes in North America by Material (2021-2030)
• Figure 12: Prefilled Syringes in North America by Usability (2021-2030)
• Figure 13: Prefilled Syringes in North America by End User (2021-2030)
• Figure 14: Prefilled Syringes in North America by Country (2021-2030)
• Figure 15: Prefilled Syringes in the US (2021-2030)
• Figure 16: Prefilled Syringes in Canada (2021-2030)
• Figure 17: Prefilled Syringes in Mexico (2021-2030)
• Figure 18: Prefilled Syringes in Europe (2021-2030)
• Figure 19: Prefilled Syringes in Europe by Product Design (2021-2030)
• Figure 20: Prefilled Syringes in Europe by Material (2021-2030)
• Figure 21: Prefilled Syringes in Europe by Usability (2021-2030)
• Figure 22: Prefilled Syringes in Europe by End User (2021-2030)
• Figure 23: Prefilled Syringes in Europe by Country (2021-2030)
• Figure 24: Prefilled Syringes in France (2021-2030)
• Figure 25: Prefilled Syringes in Germany (2021-2030)
• Figure 26: Prefilled Syringes in the United Kingdom (2021-2030)
• Figure 27: Prefilled Syringes in Italy (2021-2030)
• Figure 28: Prefilled Syringes in Spain (2021-2030)
• Figure 29: Prefilled Syringes in Russia (2021-2030)
• Figure 30: Prefilled Syringes in Rest of Europe (2021-2030)
• Figure 31: Prefilled Syringes in APAC (2021-2030)
• Figure 32: Prefilled Syringes in APAC by Product Design (2021-2030)
• Figure 33: Prefilled Syringes in APAC by Material (2021-2030)
• Figure 34: Prefilled Syringes in APAC by Usability (2021-2030)
• Figure 35: Prefilled Syringes in APAC by End User (2021-2030)
• Figure 36: Prefilled Syringes in APAC by Country (2021-2030)
• Figure 37: Prefilled Syringes in China (2021-2030)
• Figure 38: Prefilled Syringes in Japan (2021-2030)
• Figure 39: Prefilled Syringes in India (2021-2030)
• Figure 40: Prefilled Syringes in Australia (2021-2030)
• Figure 41: Prefilled Syringes in South Korea (2021-2030)
• Figure 42: Prefilled Syringes in Rest of APAC (2021-2030)
• Figure 43: Prefilled Syringes in Rest of World (2021-2030)
• Figure 44: Prefilled Syringes in RoW by Product Design (2021-2030)
• Figure 45: Prefilled Syringes in RoW by Material (2021-2030)
• Figure 46: Prefilled Syringes in RoW by Usability (2021-2030)
• Figure 47: Prefilled Syringes in RoW by End User (2021-2030)
• Figure 48: Prefilled Syringes in RoW by Region (2021-2030)
• Figure 49: Prefilled Syringes in Middle East (2021-2030)
• Figure 50: Prefilled Syringes in Africa (2021-2030)
• Figure 51: Prefilled Syringes in South America (2021-2030)
• Figure 52: Market Drivers
• Figure 53: Market Barriers
• Figure 54: Marker Opportunities
• Figure 55: PORTER'S Five Force Analysis

Prefilled Syringes Market By Product Design (Staked Needle System, Luer Cone System, and Luer Lock System), By Material (Glass and Polymer), By Usability (Reusable And Disposable), and By End User (Hospitals & Clinics, Ambulatory Surgical Centers, and Homecare Settings), By Geography is expected to grow at a steady CAGR forecast till 2030 owing to the rising prevalence of chronic diseases such as diabetes and increasing popularity of biologic drugs specifically vaccines.

Global Prefilled Syringes Market was valued at USD 11.48 billion in 2023, growing at a CAGR of 10.44% during the forecast period from 2024 to 2030 to reach USD 20.83 billion by 2030. The demand for prefilled syringes is witnessing growth due to the growing prevalence of chronic diseases and autoimmune disorders such as diabetes and rheumatoid arthritis respectively, increasing popularity of biologic drugs, rising popularity of self-administration of drugs, offer a convenient alternative to conventional syringes and vials.

Prefilled Syringes Market Dynamics:

The prefilled syringes market is witnessing an increase in market revenue due to the rising prevalence of various chronic diseases such as diabetes. According to the Ninth Edition of the International Diabetes Federation (IDF) Diabetes Atlas, globally, in 2019, there were approximately 463 million adults in the 20-79 age group suffering from diabetes. The source stated that the number of diabetic patients across the globe is expected to rise to 700 million by 2045. Additionally, 374 million people are at increased risk of developing type 2 diabetes. In addition to the above facts, according to the IDF, in 2019, an estimated 223 million women globally (2,079 years of age) were living with diabetes in 2019 and is further set to grow to 343 million by 2045.

Prefilled syringes are one of the most popular devices that have gained importance over the years due to their ease of use and other advantages over traditional insulin syringes.

Prefilled syringes are easy to use, portable and discreet in appearance, safer to administer drugs, require less time than their traditional counterparts, and prove to be more convenient to use.

Another key factor instrumental in the growth of the prefilled syringes is the rising popularity of biologic drugs.. While small molecule drugs can generally be taken orally, complex proteins and peptides of biologics in tablet form are rarely effective. This is why less invasive forms of delivery are such as prefilled syringes are becoming the choice of containers for the packaging of biologic drugs, thereby boosting the product demand in the prefilled syringes market.

However, challenges in the manufacture of prefilled syringes, and availability of alternative products such as conventional needles and syringes may prove to be certain restraints to the prefilled syringes market growth.

Prefilled Syringes Market Segment Analysis:

Prefilled Syringes Market by Product Design (Staked Needle System, Luer Cone System, and Luer Lock System), Prefilled Syringes Market by Material (Glass and Polymer), Prefilled Syringes Market by Usability (Reusable and Disposable), Prefilled Syringes Market by End User (Hospitals & Clinics, Ambulatory Surgical Centers, Homecare Settings, and Others), and Prefilled Syringes Market by Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the material segment of the prefilled syringes market, there is expected to be a shift from glass to polymer (plastic) syringes in the forecast period in order to overcome the shortcomings of the prefilled syringes made of glass. For instance, silicone oil (used to lubricate the inner surface of glass pre-filled syringe) is seen as a key factor which cannot be avoided in the manufacture of glass prefilled syringes yet is known to interfere with the properties of the biologics. Silicone is needed to ensure functionality, for components for prefilled syringes such as the plunger but silicone can alter sensitive proteins under certain conditions-causing them to aggregate or change their form. Therefore, polymer prefilled syringes are now being preferred over the glass prefilled syringes. The polymer prefilled syringes have high barrier properties against water vapor and oxygen, thereby effectively protecting the contents of the syringe. These syringes are also transparent, and are remarkably similar in appearance to glass syringes. This transparency also makes it easy to visually check content for haze, particles, and other imperfections. The Cyclo-Olefin-Polymer (COP) syringes are also much more resistant to breakage than their glass counterparts. Thus, the factors mentioned above are going to be instrumental in the increasing demand for plastic prefilled syringes in the forecast period.

North America is expected to dominate the overall Prefilled Syringes Market:

Among all the regions, North America is expected to account for the significant market share in the prefilled syringes market. North America is predicted to account for the dominant market share because of the high prevalence of autoimmune disorders, chronic diseases, rising population of the elderly as well as high awareness among people regarding disease management and the new product launches in the region.

The North American prefilled syringes market is witnessing an upward trend due to the rising prevalence of autoimmune diseases among other factors. In a study published in the journal Arthritis and Rheumatology by Dinse et al. in 2020, the researchers found that the prevalence of antinuclear antibodies (ANA), the most common biomarkers of autoimmunity, is increasing significantly in the United States in general, and more specifically in certain groups.

As per the data provided by the Public Health Agency of Canada, in 2019, approximately 374,000 (1.2%) Canadians age 16 and older were living with diagnosed rheumatoid arthritis, and 23,000 (0.8 per 1,000 people per year) were newly diagnosed in 2016-2017. The prevalence and incidence of diagnosed rheumatoid arthritis generally increases with age and is higher in women (1.7% and 1.0 per 1000 people per year, respectively) than in men (0.8% and 0.5 per year, respectively 1000 people per year).

Therefore, in order to cater to the medical needs of the large population suffering from autoimmune diseases such as RA, a number of medications are available in the prefilled syringes form. A few of them include Humira, Kevzara, and Enbrel which are available in the prefilled syringe form.

The above-mentioned facts point towards the presence of diverse patient pool in the country as well as region that may benefit from the utilization of prefilled syringes. Furthermore, the well-established patient care system along with awareness among patients and caregivers regarding different types of prefilled syringes is further expected to propel the North American prefilled syringes market growth.

Moreover, the prompt and well-established healthcare services and infrastructure further contributes to the growth of the regional prefilled syringes market. The presence of key players in the region and supportive reimbursement programs further provide immense growth opportunities for prefilled syringes market. For instance, in July 2022, Fresnius Kabi launched ready-to-administer prefilled fentanyl syringe in the 1 ml volume format which is designed to cut waste and diversion by eliminating the possibilities of potential errors.

Prefilled Syringes Market Key Players:

Some of the key market players operating in the prefilled syringes market includes BD, NIPRO Pharma, Taisei Kako Co.,Ltd, TERUMO PHARMACEUTICAL SOLUTIONS., SCHOTT AG, Gerresheimer AG, West Pharmaceutical Services, Inc., Dali Medical Devices, Stevanato Group, Credence MedSystems, Inc., Baxter, MAEDA INDUSTRY Co., Ltd., MedXL Inc, IRISYS, LLC, Sandoz International GmbH, Pfizer Inc., Vetter, Weigao Group, Fresenius Kabi, Catalent Inc and others.

Recent Developmental Activities in Prefilled Syringes Market:

In May 2022, Glenmark Pharmaceuticals Limited received the US Food and Drug Administration approval for the Icatibant Injection, 30 mg/3 mL (10 mg/mL) Single-Dose Prefilled Syringe.

In April 2022, Roche received the approval from the US FDA for the supplemental Biologics License Application of the company for Xolair® (omalizumab) prefilled syringe for self-injection across all approved U.S. indications.

In March 2022, Zealand Pharma announced the US FDA approval for the Zegalogue® (dasiglucagon) injection which is available in the prefilled syringe form, for the treatment of diabetes.

Key Takeaways from the Prefilled Syringes Market Report Study

Market size analysis for current prefilled syringes market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the prefilled syringes market.

Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years

Key companies dominating the global prefilled syringes market.

Various opportunities available for the other competitor in the prefilled syringes market space.

What are the top performing segments in 2023? How these segments will perform in 2030?

Which is the top-performing regions and countries in the current prefilled syringes market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for prefilled syringes market growth in the coming future?

Target Audience who can be benefited from this Prefilled Syringes Market Report Study

Prefilled Syringes products providers

Research organizations and consulting companies

Prefilled Syringes-related organization, association, forum, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in prefilled syringes

Various End-users who want to know more about the prefilled syringes market and latest technological developments in the prefilled syringes market.

Frequently Asked Questions for Prefilled Syringes Market:

1. What is a Prefilled Syringe?

A pre-filled syringe come preloaded with a single dose substance usually drug or vaccine to be injected with a needle. Pre-filled syringes with pre measure dosages helps to reduce dosing errors with increase patient compliance.

2. What is the market for Global Prefilled Syringes?

Global Prefilled Syringes Market was valued at USD 11.48 billion in 2023, growing at a CAGR of 10.44% during the forecast period from 2024 to 2030 to reach USD 20.83 billion by 2030.

3. What are the drivers for Global Prefilled Syringes Market?

The demand for prefilled syringes is witnessing growth due to the growing prevalence of chronic diseases and autoimmune disorders, increasing popularity of biologic drugs, rising popularity of self-administration of drugs, and a safe alternative to conventional syringes, and vials.

4. What are the key players operating in Global Prefilled Syringes Market?

Some of the key market players operating in the prefilled syringes market includes BD, NIPRO Pharma, Taisei Kako Co.,Ltd, TERUMO PHARMACEUTICAL SOLUTIONS., SCHOTT AG, Gerresheimer AG, West Pharmaceutical Services, Inc., Dali Medical Devices, Stevanato Group, Credence MedSystems, Inc., Baxter, MAEDA INDUSTRY Co., Ltd., MedXL Inc, IRISYS, LLC, Sandoz International GmbH, Pfizer Inc., Vetter, Weigao Group, Fresenius Kabi, Catalent Inc and others..

5. Which region has the highest share in Prefilled Syringes market?

Among all the regions, North America is expected to account for the significant market share in the prefilled syringes market. North America is predicted to account for the dominant market share because of the high prevalence of autoimmune disorders, chronic diseases, rising population of the elderly as well as high awareness among people regarding disease management and the new product launches other factors in the region.

Table of Contents

1.Prefilled Syringes Market Report Introduction

2. Prefilled Syringes Market Executive Summary

• 2.1. Scope of the Study
• 2.2. Market at Glance
• 2.3. Competitive Assessment
• 2.4. Financial Benchmarking

3. Regulatory and Patent Analysis

• 3.1. The United States
• 3.2. Europe
  • 3.2.1. Germany
  • 3.2.2. France
  • 3.2.3. Italy
  • 3.2.4. Spain
  • 3.2.5. U.K.
• 3.3. Japan

4. Prefilled Syringes Market Key Factors Analysis

• 4.1. Prefilled Syringes Market Drivers
  • 4.1.1. Rising Prevalence of Chronic Diseases
  • 4.1.2. Rising Popularity of Biologic Drugs
  • 4.1.3. Ease of Self Administration of Drugs
  • 4.1.4. Increasing Focus on Improving Safety of Prefilled Syringes
• 4.2. Prefilled Syringes Market Restraints and Challenges
  • 4.2.1. Challenges in the Manufacturing of Prefilled Syringes
  • 4.2.2. Availability of Alternative Products
• 4.3. Prefilled Syringes Market Opportunities
  • 4.3.1. Targeting Emerging Markets for Product Launches
  • 4.3.2. Product Improvement in Terms of Safety

5. Prefilled Syringes Market Porter's Five Forces Analysis

• 5.1. Bargaining Power of Suppliers
• 5.2. Bargaining Power of Consumers
• 5.3. Threat of New Entrants
• 5.4. Threat of Substitutes
• 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Prefilled Syringes Market

7. Prefilled Syringes Market Layout

• 7.1. By Product Design
  • 7.1.1. Staked Needle System
  • 7.1.2. Luer Cone System
  • 7.1.3. Luer Lock System
• 7.2. By Material
  • 7.2.1. Glass
  • 7.2.2. Polymer
• 7.3. By Usability
  • 7.3.1. Reusable
  • 7.3.2. Disposable
• 7.4. By End User
  • 7.4.1. Hospitals & Clinics
  • 7.4.2. Ambulatory Surgical Centers
  • 7.4.3. Homecare Settings
• 7.5. By Geography
  • 7.5.1. North America
    • 7.5.1.1. North America Prefilled Syringes Market, by Product Design
    • 7.5.1.2. North America Prefilled Syringes Market, by Material
    • 7.5.1.3. North America Prefilled Syringes Market, by Usability
    • 7.5.1.4. North America Prefilled Syringes Market, by End User
    • 7.5.1.5. North America Prefilled Syringes Market, by Country
    • 7.5.1.3.1. United States
    • 7.5.1.3.2. Canada
    • 7.5.1.3.3. Mexico
  • 7.5.2. Europe
    • 7.5.2.1. Europe Prefilled Syringes Market, by Product Design
    • 7.5.2.2. Europe Prefilled Syringes Market, by Material
    • 7.5.2.3. Europe Prefilled Syringes Market, by Usability
    • 7.5.2.4. Europe Prefilled Syringes Market, by End User
    • 7.5.2.5. Europe Prefilled Syringes Market, by Country
    • 7.5.2.3.1. France
    • 7.5.2.3.2. Germany
    • 7.5.2.3.3. United Kingdom
    • 7.5.2.3.4. Italy
    • 7.5.2.3.5. Spain
    • 7.5.2.3.6. Russia
    • 7.5.2.3.7. Rest of Europe
  • 7.5.3. Asia-Pacific
    • 7.5.3.1. Asia-Pacific Prefilled Syringes Market, by Product Design
    • 7.5.3.2. Asia-Pacific Prefilled Syringes Market, by Material
    • 7.5.3.3. Asia-Pacific Prefilled Syringes Market, by Usability
    • 7.5.3.4. Asia-Pacific Prefilled Syringes Market, by End User
    • 7.5.3.5. Asia-Pacific Prefilled Syringes Market, by Country
    • 7.5.3.3.1. China
    • 7.5.3.3.2. Japan
    • 7.5.3.3.3. India
    • 7.5.3.3.4. Australia
    • 7.5.3.3.5. South Korea
    • 7.5.3.3.6. Rest of Asia Pacific
  • 7.5.4. Rest of the World (RoW)
    • 7.5.4.1. RoW Prefilled Syringes Market, by Product Design
    • 7.5.4.2. RoW Prefilled Syringes Market, by Material
    • 7.5.4.3. RoW Prefilled Syringes Market, by Usability
    • 7.5.4.4. RoW Prefilled Syringes Market, by End User
    • 7.5.4.5. RoW Prefilled Syringes Market, by Country
    • 7.5.4.3.1. Middle East
    • 7.5.4.3.2. Africa
    • 7.5.4.3.3. South America

8. Prefilled Syringes Market Global Company Share Analysis - Key 3-5 Companies

9. Prefilled Syringes Market Company and Product Profiles

• 9.1. BD
  • 9.1.1. Company Overview
  • 9.1.2. Company Snapshot
  • 9.1.3. Financial Overview
  • 9.1.4. Product Listing
  • 9.1.5. Entropy
• 9.2. NIPRO Pharma
  • 9.2.1. Company Overview
  • 9.2.2. Company Snapshot
  • 9.2.3. Financial Overview
  • 9.2.4. Product Listing
  • 9.2.5. Entropy
• 9.3. Taisei Kako Co.,Ltd
  • 9.3.1. Company Overview
  • 9.3.2. Company Snapshot
  • 9.3.3. Financial Overview
  • 9.3.4. Product Listing
  • 9.3.5. Entropy
• 9.4. TERUMO PHARMACEUTICAL SOLUTIONS
  • 9.4.1. Company Overview
  • 9.4.2. Company Snapshot
  • 9.4.3. Financial Overview
  • 9.4.4. Product Listing
  • 9.4.5. Entropy
• 9.5. SCHOTT AG
  • 9.5.1. Company Overview
  • 9.5.2. Company Snapshot
  • 9.5.3. Financial Overview
  • 9.5.4. Product Listing
  • 9.5.5. Entropy
• 9.6. Gerresheimer AG
  • 9.6.1. Company Overview
  • 9.6.2. Company Snapshot
  • 9.6.3. Financial Overview
  • 9.6.4. Product Listing
  • 9.6.5. Entropy
• 9.7. West Pharmaceutical Services, Inc.
  • 9.7.1. Company Overview
  • 9.7.2. Company Snapshot
  • 9.7.3. Financial Overview
  • 9.7.4. Product Listing
  • 9.7.5. Entropy
• 9.8. Dali Medical Devices
  • 9.8.1. Company Overview
  • 9.8.2. Company Snapshot
  • 9.8.3. Financial Overview
  • 9.8.4. Product Listing
  • 9.8.5. Entropy
• 9.9. Stevanato Group
  • 9.9.1. Company Overview
  • 9.9.2. Company Snapshot
  • 9.9.3. Financial Overview
  • 9.9.4. Product Listing
  • 9.9.5. Entropy
• 9.10. Credence MedSystems, Inc.
  • 9.10.1. Company Overview
  • 9.10.2. Company Snapshot
  • 9.10.3. Financial Overview
  • 9.10.4. Product Listing
  • 9.10.5. Entropy
• 9.11. Baxter
  • 9.11.1. Company Overview
  • 9.11.2. Company Snapshot
  • 9.11.3. Financial Overview
  • 9.11.4. Product Listing
  • 9.11.5. Entropy
• 9.12. MAEDA INDUSTRY Co., Ltd.
  • 9.12.1. Company Overview
  • 9.12.2. Company Snapshot
  • 9.12.3. Financial Overview
  • 9.12.4. Product Listing
  • 9.12.5. Entropy
• 9.13. MedXL Inc
  • 9.13.1. Company Overview
  • 9.13.2. Company Snapshot
  • 9.13.3. Financial Overview
  • 9.13.4. Product Listing
  • 9.13.5. Entropy
• 9.14. IRISYS, LLC
  • 9.14.1. Company Overview
  • 9.14.2. Company Snapshot
  • 9.14.3. Financial Overview
  • 9.14.4. Product Listing
  • 9.14.5. Entropy
• 9.15. Sandoz International GmbH
  • 9.13.1. Company Overview
  • 9.13.2. Company Snapshot
  • 9.13.3. Financial Overview
  • 9.13.4. Product Listing
  • 9.13.5. Entropy
• 9.16. Pfizer Inc
  • 9.16.1. Company Overview
  • 9.16.2. Company Snapshot
  • 9.16.3. Financial Overview
  • 9.16.4. Product Listing
  • 9.16.5. Entropy
• 9.17. Vetter
  • 9.17.1. Company Overview
  • 9.17.2. Company Snapshot
  • 9.17.3. Financial Overview
  • 9.17.4. Product Listing
  • 9.17.5. Entropy
• 9.18. Weigao Group
  • 9.18.1. Company Overview
  • 9.18.2. Company Snapshot
  • 9.18.3. Financial Overview
  • 9.18.4. Product Listing
  • 9.18.5. Entropy
• 9.19. Fresenius Kabi
  • 9.19.1. Company Overview
  • 9.19.2. Company Snapshot
  • 9.19.3. Financial Overview
  • 9.19.4. Product Listing
  • 9.19.5. Entropy
• 9.20. Catalent, Inc
  • 9.20.1. Company Overview
  • 9.20.2. Company Snapshot
  • 9.20.3. Financial Overview
  • 9.20.4. Product Listing
  • 9.20.5 Entropy

10. Project Approach

• 10.1. Secondary Sources
• 10.2. Primary Sources
• 10.3. Data Triangulation
• 10.4. Key Expert Opinions

11. KOL Views

12. DelveInsight Capabilities

13. Disclaimer

14. About DelveInsight